Hepatocellular Carcinoma: A Phase II Randomized Controlled Double-Blind Trial of Transarterial Chemoembolization in Combination with Biweekly Intravenous Administration of Bevacizumab or a Placebo

Journal article published in 2015 by Matthias Pinter, Gregor Ulbrich, Wolfgang Sieghart, Claus Kölblinger, Thomas Reiberger, Shuren Li, Arnulf Ferlitsch, Christian Müller, Johannes Lammer, Markus Peck-Radosavljevic

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving allowed

Upload

Published version: archiving restricted

Upload

Policy details

Data provided by